Status: Recruiting
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
The goal of this study is to evaluate the antiemetic efficacy and drug safety of ondansetron orodispersible film in pediatric patients with malignant tumors who received moderate emetic risk radiation induced vomiting, and to formulate reasonable and effective clinical medication regimen for preventing vomiting caused by moderate emetic risk radiation in children with malignant tumor.
Participants needed: 60
Trial details
Phase: Phase 4Age: 1-14Biological sex: AllType: InterventionalSponsor: Chongqing University Cancer HospitalUpdated: Oct 20, 2025Locations: 1
Eligibility criteria
Children with malignant tumors diagnosed by histopathology [+9]
The nausea and vomiting caused by the surgery have not fully recovered if the su... [+9]